HAO:NSD-Haoxi Health Technology Limited Class A Ordinary Shares (USD)

COMMON STOCK | Advertising Agencies |

Last Closing

USD 1.4886

Change

+0.07 (+5.05)%

Market Cap

N/A

Volume

150.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap
ADVWW Advantage Solutions Inc

N/A

USD 3.69B
CRTO Criteo Sa

-1.05 (-3.82%)

USD 1.58B
STGW Stagwell Inc

-0.29 (-5.78%)

USD 1.57B
MGNI Magnite Inc

-0.53 (-3.30%)

USD 1.38B
ZD Ziff Davis Inc

-1.88 (-5.74%)

USD 1.37B
IAS Integral Ad Science Holding LL..

-0.24 (-2.95%)

USD 1.10B
QNST QuinStreet Inc

-0.47 (-3.01%)

USD 0.84B
NEXN Nexxen International Ltd

-0.23 (-2.00%)

USD 0.74B
NCMI National CineMedia Inc

-0.24 (-4.62%)

USD 0.48B
ADV Advantage Solutions Inc

-0.08 (-6.40%)

USD 0.48B

ETFs Containing HAO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Advertising Agencies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -58.01% 17% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.01% 17% F 8% B-
Trailing 12 Months  
Capital Gain -99.05% 4% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.05% 4% F 1% F
Trailing 5 Years  
Capital Gain -99.76% 8% B- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.76% 8% B- 2% F
Average Annual (5 Year Horizon)  
Capital Gain -17.54% 33% F 16% F
Dividend Return -17.54% 33% F 16% F
Total Return N/A 50% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 35.53% 70% C- 50% F
Risk Adjusted Return -49.37% 37% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.